Immutep (IMMP) Change in Receivables (2012 - 2024)
Immutep's (IMMP) quarterly Change in Receivables came in at $396577.9 in Q2 2024, up 136.91% YoY from $167398.0 in Q3 2023, and up 136.91% on a QoQ basis from -$1.1 million in Q2 2023.
Immutep (IMMP) Change in Receivables (2012 - 2024) Analysis & Trends
Immutep (IMMP) has 8 years of Change in Receivables data on file, last reported at $396577.9 in Q2 2024.
- Quarterly Change in Receivables rose 136.91% year-over-year to $396577.9 in Q2 2024, while the trailing twelve-month figure through Jun 2024 was -$666689.5 (up 74.21% YoY) and the FY2024 annual result came in at $396577.9, up 136.91% from the prior year.
- Change in Receivables rose to $396577.9 in Q2 2024, from -$1.1 million in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $1.2 million in Q2 2020 to a low of -$1.1 million in Q2 2023.
- A 3-year average of $189211.7 and a median of $396577.9 in 2024 frame the typical range for Change in Receivables.
- Annual changes were most pronounced in 2020 — Change in Receivables soared 200.91% — and 2024, when it soared 136.91%.
- Tracing IMMP's Change in Receivables over 3 years: stood at $1.2 million in 2020, then tumbled by 186.27% to -$1.1 million in 2023, then soared by 136.91% to $396577.9 in 2024.
- The last three Change in Receivables figures came in at $396577.9 (Q2 2024), -$1.1 million (Q2 2023), and $1.2 million (Q2 2020), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 140.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 838.50 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -53.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 117.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 31.60 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 94.29 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 37.16 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Immutep | 56.46 Mn | -8.63 Mn | - | 24.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 396,577.87 |
| Jun 30, 2024 | 396,577.87 |
| Jun 30, 2023 | -1.07 Mn |
| Jun 30, 2023 | -1.07 Mn |
| Jun 30, 2020 | 1.25 Mn |
| Jun 30, 2020 | 1.25 Mn |
| Jun 30, 2019 | -1.23 Mn |
| Jun 30, 2019 | -1.23 Mn |
| Jun 30, 2017 | -1.52 Mn |
| Jun 30, 2017 | -1.52 Mn |
| Jun 30, 2016 | -294,889.21 |
| Jun 30, 2016 | -294,889.21 |
| Jun 30, 2015 | 4.63 Mn |
| Jun 30, 2015 | 4.63 Mn |
| Jun 30, 2012 | -247,060.33 |
| Jun 30, 2012 | -247,060.33 |